01 Sep 4Dx retail round closes with full subscription
We are pleased to announce that our recent retail offer of shares is now fully subscribed after successfully raising AU$500,000.
It is very encouraging to gain backing so enthusiastically from retail investors committed to seeing our technology come to market as fast as possible.
These funds take us a step closer to commercialising our technology through ongoing clinical validation and expansion of our US operation, where Founder and CEO, Andreas Fouras, is now based.
We would like to thank all of our investors for their ongoing support and will continue to update you with news as we reach significant milestones.
To find out about future opportunities, please register your interest here.